Review article:: safe amounts of gluten for patients with wheat allergy or coeliac disease

被引:173
作者
Hischenhuber, C
Crevel, R
Jarry, B
Mäki, M
Moneret-Vautrin, DA
Romano, A
Troncone, R
Ward, R
机构
[1] Nestle, Nestec Qual Management, Vevey, Switzerland
[2] Unilever, Safety & Environm Assurance Ctr, Bedford, England
[3] ACS Partners, Paris, France
[4] Univ Tampere, Paediat Res Ctr, Sch Med, FIN-33101 Tampere, Finland
[5] Tampere Univ Hosp, Tampere, Finland
[6] Univ Nancy, Hop Cent, Nancy, France
[7] Univ Cattolica Sacro Cuore, CI Columbus, Rome, Italy
[8] Oasi Maria SS, Troina, Italy
[9] Univ Naples Federico II, Dept Paediat, Naples, Italy
[10] Univ Naples Federico II, European Lab Invest Food Induced Dis, Naples, Italy
[11] PepsiCo Int, Leicester, Leics, England
关键词
D O I
10.1111/j.1365-2036.2006.02768.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
For both wheat allergy and coeliac disease the dietary avoidance of wheat and other gluten-containing cereals is the only effective treatment. Estimation of the maximum tolerated amount of gluten for susceptible individuals would support effective management of their disease. Literature was reviewed to evaluate whether an upper limit for gluten content in food, which would be safe for sufferers from both diseases, could be identified. When setting gluten limits for coeliac disease sufferers, the overall potential daily intake should be considered, while for wheat allergy limits should be based on single servings. For coeliac disease sufferers this limit should lie between 10 and 100 mg daily intake. For wheat allergy, lowest eliciting doses for children lie in the lower milligram range, while for adults they are most significantly higher. Gliadins (part of the gluten proteins) not only trigger coeliac disease, but are also major allergens in wheat allergy. Therefore, measurement of gliadins with validated enzyme-linked immunosorbent assay methods provides an appropriate marker for assessing gluten and/or wheat protein contents in food. Available data suggest that a maximum gluten content for 'gluten-free' foods could be set, which protects both wheat allergy sufferers and coeliac patients.
引用
收藏
页码:559 / 575
页数:17
相关论文
共 156 条
[1]   Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation [J].
Aihara, M ;
Miyazawa, M ;
Osuna, H ;
Tsubaki, K ;
Ikebe, T ;
Aihara, Y ;
Ikezawa, Z .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) :466-472
[2]   DENTAL ENAMEL DEFECTS IN CELIAC-DISEASE [J].
AINE, L ;
MAKI, M ;
COLLIN, P ;
KEYRILAINEN, O .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1990, 19 (06) :241-245
[3]   In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[4]  
[Anonymous], COELIAC DIS 100 YEAR
[5]   The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase [J].
Arentz-Hansen, H ;
Körner, R ;
Molberg, O ;
Quarsten, H ;
Vader, W ;
Kooy, YMC ;
Lundin, KEA ;
Koning, F ;
Roepstorff, P ;
Sollid, LM ;
McAdam, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :603-612
[6]   Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues [J].
Arentz-Hansen, H ;
McAdam, SN ;
Molberg, O ;
Fleckenstein, B ;
Lundin, KEA ;
Jorgensen, TJD ;
Jung, G ;
Roepstorff, P ;
Sollid, LM .
GASTROENTEROLOGY, 2002, 123 (03) :803-809
[7]   Allergy after ingestion or inhalation of cereals involves similar allergens in different ages [J].
Armentia, A ;
Rodríguez, R ;
Callejo, A ;
Martín-Esteban, M ;
Martín-Santos, JM ;
Salcedo, G ;
Pascual, C ;
Sánchez-Monge, R ;
Pardo, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (08) :1216-1222
[8]   DETECTION OF CONTINUING GLUTEN INGESTION IN TREATED CELIAC PATIENTS [J].
BAKER, PG ;
BARRY, RE ;
READ, AE .
BRITISH MEDICAL JOURNAL, 1975, 1 (5956) :486-488
[9]   IGE ANTIBODIES TO WHEAT-FLOUR COMPONENTS - STUDIES WITH SERA FROM SUBJECTS WITH BAKERS ASTHMA OR CELIAC CONDITION [J].
BALDO, BA ;
WRIGLEY, CW .
CLINICAL ALLERGY, 1978, 8 (02) :109-124
[10]   A BARLEY FLOUR INHIBITOR OF INSECT ALPHA-AMYLASE IS A MAJOR ALLERGEN ASSOCIATED WITH BAKERS ASTHMA DISEASE [J].
BARBER, D ;
SANCHEZMONGE, R ;
GOMEZ, L ;
CARPIZO, J ;
ARMENTIA, A ;
LOPEZOTIN, C ;
JUAN, F ;
SALCEDO, G .
FEBS LETTERS, 1989, 248 (1-2) :119-122